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INTRODUCTION
The average life span of modern people has been extended, while cognitive function-related degenerative diseases such as vascular dementia and Alzheimer's dementia have increased [1] . However, the clear cause of cognitive decline has not been clarified yet, so the interest and concern of the medical community are increasing on the methods for cognitive function preservation [2] .
Age-associated memory impairment (AAMI) is a diagnostic term that applies to healthy people aged 50 years or older who have experienced gradual memory impairment [3] .
Although they have fewer behavioral disabilities compared to cognitive disorders such as Alzheimer's disease, it refers to a state of considerable difficulty in living for the elderly. There is also a similar definition of subjective memory impairment (SMI). These age-related subjective memory disorders have been considered to reflect a decline in objective cognitive function and to be associated with early dementia, but some studies have shown that subjective memory disorders is more associated with depression, anxiety, personality and education than emotional cognitive decline [4] [5] [6] .
Mild cognitive impairment (MCI) is a broad concept that refers to the intermediate stage between normal aging and dementia. Therefore, the patient can be defined as MCI when there are complaints about memory deterioration by the patient or caregiver report, good activities of daily living, normal cognitive ability, abnormal memory, but not dementia [7] . Approximately 80% of patients with MCI develop into dementia within 10 years, and unlike dementia, neurons are not yet destroyed, which is a clinically important period for reversible changes [8] . According to an empirical study on MCI, symptoms of early memory impairment are related to neuro-pathologic changes in the limbic system and eventually to Alzheimer's disease, but the accumulation of research is insufficient [9, 10] .
Currently, screening and intervention at the pre-dementia stage are known to be the best way to prevent dementia, but the controversy about the linkage between AAMI or MCI and dementia continues [11] . Therefore, the relationship and the difference between AAMI and MCI should be clarified to be helpful for appropriate prevention and treatment of patients who suffered from memory impairment depending on the status. Our study aimed to investigate the characteristics of each of AAMI and MCI and compared neurocognitive function in healthy Korean adults.
MATERIALS AND METHODS

Survey overview and study population
We retrospectively reviewed the medical records of 23 par- 
Definition of AAMI and MCI
To date, the assessment questionnaire for AAMI is the memory assessment clinic-questionnaire (MAC-Q), which is the most concise statement of AAMI. MAC-Q consists of 6 items, each of which can be answered on a scale of 1 to 5 points and a total score of 30 points. The higher the score, the more the participants feel difficulty about their memory.
If at least one of the 4 or 5 points is recorded, it will be de-fined as AAMI [12] . Since there is no official Korean version of MAC-Q, we made a translation in cooperation with the Korean translation institute, and we need to study for validation with a large sample size. We defined AAMI as 4 or 5 points in at least one item in MAC-Q, Korean mini-mental state exam (K-MMSE) score of 27 points or more and Korean activities of daily living (K-ADL) as a group with no serious dysfunctions. A similar concept of AAMI is SMI, which uses the subjective memory complaint questionnaire as a tool to assess it in Korea. If the score is 6 or more out of Data are expressed as the number (percentage). AAMI, age related memory impairment; MCI, mild cognitive impairment.
In the diagnostic criteria proposed by Petersen et al., MCI has a memory impairment in the caregiver and the patient and shows objectively decreased memory compared to the age, but the overall cognitive function should be preserved [14] .
Therefore, we defined MCI as a group that received 4 or 5
points in at least one item in MAC-Q, K-MMSE score of 24 or more, and no severe dysfunction in K-ADL. There is a Montréal cognitive functional assessment (MoCA), which is known to be useful for assessing MCI, and we also used this questionnaire as an additional tool in this study [15] .
Morningness-eveningness questionnaire is useful to assess the sleep/wake cycle or circadian patterns of human [16] . Table 1 shows the demographic and biochemical characteristics of the participants in relation to memory impairment status. The mean values of several metabolic variables, weight, fasting glucose, and cholesterol tend to be higher in the AAMI group than in the normal and MCI group, statistically not significant. Only the LDL cholesterol was statistically significantly higher in the AAMI group. Other metabolic variables, BMI, fasting insulin, triglyceride and homocysteine were the higher in the MCI group than in the normal and AAMI group. Table 2 , Figure 1 The difference between the MCI and AAMI groups was statistically significant in the parietal lobe. Table 3 and Table   4 show the results of Kruskal-Wallis test to compare the cat- Figure 1 . A composite picture of glucose metabolism using positron emission tomography and the tracer fluorodeoxyglucose. Patient with age-associated memory impairment on the right shows reduced glucose metabolism in the bilateral frontal lobes and left temporal lobe. There is also decreased uptake in right parietal and temporal lobes with lesser degree, and slightly increased uptake in right basal ganglia.
Statistical analysis
RESULTS
Figure 2.
Comparisons of decreased foci detected by brain positron emission tomography/computed tomography between age associated memory impairment (AAMI) and mild cognitive impairment (MCI) groups. The AAMI patient (A) shows moderately decreased glucose metabolism in the cerebellum and mild degree of decreased uptake in bilateral inferior temporal lobes. Another AAMI patient (B) shows focal glucose hypometabolism in right parietal lobe: Probably partial volume effect or atrophy (sulcus widening). The MCI patient (C) shows mild degree of glucose hypometabolism in both frontal lobes and insula.
egories of neurocognitive function with K-MMSE and
MoCA among the three groups, and MCI group showed marked deterioration of in attention (P value=0.030), and decreased neurocognitive function in more various domains than AAMI group with K-MMSE.
DISCUSSION
In this study, we found that mean values of several metabolic parameters, such as LDL cholesterol, BMI, fasting in-sulin, triglyceride and homocysteine were the higher in the AAMI and MCI group than normal group. MCI group showed a significant metabolic reduction in the parietal lobe and decreased function in more various domains than AAMI group. These findings mean MCI group had more deleterious cognitive function and could develop into the dementia.
Previous study showed that 15% of patients diagnosed with MCI proceeded to dementia annually, which supported our result. Interestingly, AAMI also correlated with metabolic parameters, such as weight, fasting glucose, total cholesterol and Ji-Hye Kim, Ji-Won Lee: Neurocognitive Function and Neuroimaging between AAMI and MCI 23 [18] . On the contrary, several observational studies have suggested that SMI is more associated with depression, anxiety, personality and education than cognitive decline [19] . Alzheimer's disease [21] . Our study also showed that the metabolism in temporal lobes and pariatal lobes tended to decrease in the AAMI group, and the context is the same as that in the attention domain.
Some mechanisms could explain the significant relationship between AAMI and MCI. The biomarkers that indicate Alzheimer's disease are low in amyloid  1-42, increased in total tau and phosphorylated tau. According to some studies, this characteristic is seen in patients with MCI, in a intermediate state between normal elderly and Alzheimer's disease, and can be found in cerebrospinal fluid 5 to 10 years before the onset of dementia [22] . In addition, MCI is known to have several characteristics that indicate that it is a pre-advanced stage of Alzheimer's disease in brain-induced neurofilament, brain-derived neurotrophic factor, and functional and amyloid imaging [23] .
AAMI is not significantly known to be associated with Alzheimer's disease, but also thought to be affected by several health factors, the most important mechanism of association with neurocognitive function is the insulin resistance. Although the pathophysiology of memory impairment is not fully understood, the epidemiological data suggest that brain insulin resistance flanks both cognitive decline and progressive neuro-inflammation in neurodegenerative diseases [24] . Some experimental study also reported the role of insulin in spatial memory and inflammatory process within the hippocampus for memory regulation. This mechanism may affect overall neurodegenerative disease, it can be interpreted that it is the main cause of the AAMI stage characterizing difference in from MCI [25] .
Importantly, our study had several limitations. First, it is a retrospective observational analysis of an existing database that limits causal inferences. Additional research is needed to elucidate longitudinal associations. Second, since we included participants voluntarily visited a single health center for cognitive function check-ups, there remains the possibility of selection bias. Especially, the participants who undertaken the PET/CT only for memory loss, except for those without cognitive impairment, do not have sufficient sample size. Despite these potential limitations, we provided the differences in neurocognitive function of pre-dementia patients with imaging studies including brain PET/CT.
In conclusion, there are differences in decreased foci of metabolism among normal, AAMI and MCI groups, Especially, a difference of metabolic decrease was observed in parietal lobe. In the MCI group, the deficit of neurocognitive function was the significant in attention, and showed a broader range of cognitive deficits than AAMI group. This result is not sufficient, but it can be regarded as the basis of a study to characterize AAMI and MCI. 
